Catherine Lozupone
Concepts (396)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gastrointestinal Microbiome | 27 | 2025 | 697 | 4.660 |
Why?
| | Bacteria | 40 | 2025 | 858 | 4.550 |
Why?
| | Microbiota | 23 | 2025 | 762 | 4.310 |
Why?
| | Phylogeny | 28 | 2020 | 904 | 2.470 |
Why?
| | RNA, Ribosomal, 16S | 30 | 2025 | 549 | 1.660 |
Why?
| | Software | 10 | 2022 | 665 | 1.630 |
Why?
| | HIV Infections | 18 | 2024 | 2836 | 1.600 |
Why?
| | Metagenome | 13 | 2015 | 147 | 1.590 |
Why?
| | Computational Biology | 8 | 2025 | 644 | 1.570 |
Why?
| | Gastrointestinal Tract | 13 | 2019 | 195 | 1.380 |
Why?
| | Feces | 17 | 2025 | 484 | 1.370 |
Why?
| | Biodiversity | 12 | 2018 | 409 | 1.300 |
Why?
| | Intestines | 8 | 2018 | 357 | 1.220 |
Why?
| | Interleukin-10 | 3 | 2022 | 302 | 1.220 |
Why?
| | Symbiosis | 6 | 2020 | 79 | 1.170 |
Why?
| | Dysbiosis | 5 | 2021 | 181 | 1.170 |
Why?
| | Anti-Retroviral Agents | 5 | 2024 | 233 | 0.970 |
Why?
| | Polysaccharides, Bacterial | 4 | 2025 | 70 | 0.940 |
Why?
| | Metabolome | 2 | 2019 | 350 | 0.930 |
Why?
| | Sexual and Gender Minorities | 4 | 2022 | 214 | 0.770 |
Why?
| | Leukocytes, Mononuclear | 3 | 2022 | 558 | 0.760 |
Why?
| | Bacterial Toxins | 1 | 2022 | 106 | 0.730 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2025 | 351 | 0.690 |
Why?
| | Immune System | 2 | 2019 | 177 | 0.690 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 180 | 0.680 |
Why?
| | Blood Group Antigens | 1 | 2020 | 15 | 0.670 |
Why?
| | Disease | 2 | 2019 | 98 | 0.660 |
Why?
| | Ecosystem | 10 | 2017 | 596 | 0.650 |
Why?
| | Health | 2 | 2017 | 84 | 0.620 |
Why?
| | Parkinson Disease | 1 | 2025 | 493 | 0.610 |
Why?
| | Audiovisual Aids | 1 | 2019 | 12 | 0.610 |
Why?
| | Prevotella | 1 | 2018 | 14 | 0.600 |
Why?
| | Immunotherapy | 2 | 2025 | 641 | 0.600 |
Why?
| | DNA, Bacterial | 7 | 2019 | 337 | 0.600 |
Why?
| | Bacterial Infections | 2 | 2020 | 250 | 0.590 |
Why?
| | Dolphins | 1 | 2017 | 2 | 0.570 |
Why?
| | Anti-Inflammatory Agents | 2 | 2022 | 496 | 0.540 |
Why?
| | Genetic Techniques | 2 | 2008 | 64 | 0.520 |
Why?
| | Genetic Variation | 9 | 2011 | 991 | 0.510 |
Why?
| | Soil Microbiology | 6 | 2011 | 218 | 0.510 |
Why?
| | Humans | 74 | 2025 | 137585 | 0.510 |
Why?
| | Metagenomics | 5 | 2013 | 169 | 0.500 |
Why?
| | Sequence Analysis, DNA | 11 | 2017 | 812 | 0.470 |
Why?
| | Bacterial Physiological Phenomena | 5 | 2020 | 61 | 0.460 |
Why?
| | Animals | 37 | 2025 | 36940 | 0.430 |
Why?
| | Immune Tolerance | 1 | 2016 | 363 | 0.430 |
Why?
| | Archaea | 3 | 2011 | 82 | 0.430 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2016 | 385 | 0.420 |
Why?
| | Tropheryma | 1 | 2013 | 5 | 0.420 |
Why?
| | Whipple Disease | 1 | 2013 | 6 | 0.410 |
Why?
| | Biota | 1 | 2013 | 34 | 0.410 |
Why?
| | Obesity | 5 | 2021 | 2992 | 0.400 |
Why?
| | Ecology | 3 | 2011 | 118 | 0.390 |
Why?
| | Homosexuality, Male | 4 | 2022 | 184 | 0.370 |
Why?
| | Cluster Analysis | 8 | 2010 | 499 | 0.370 |
Why?
| | Microbiological Techniques | 2 | 2010 | 30 | 0.370 |
Why?
| | Liver Transplantation | 1 | 2019 | 871 | 0.360 |
Why?
| | Genes, Bacterial | 4 | 2011 | 164 | 0.340 |
Why?
| | Host-Pathogen Interactions | 5 | 2024 | 364 | 0.340 |
Why?
| | Molecular Sequence Data | 15 | 2013 | 2900 | 0.340 |
Why?
| | Genes, Archaeal | 1 | 2008 | 6 | 0.300 |
Why?
| | Glycosyltransferases | 1 | 2008 | 11 | 0.300 |
Why?
| | Glycoside Hydrolases | 1 | 2008 | 26 | 0.300 |
Why?
| | Data Interpretation, Statistical | 1 | 2010 | 363 | 0.290 |
Why?
| | Inflammation | 5 | 2024 | 2837 | 0.290 |
Why?
| | Antigens, CD | 3 | 2025 | 521 | 0.280 |
Why?
| | Isoleucine | 2 | 2005 | 15 | 0.270 |
Why?
| | Hot Springs | 1 | 2007 | 9 | 0.270 |
Why?
| | Digestive System | 1 | 2007 | 27 | 0.270 |
Why?
| | Geologic Sediments | 1 | 2007 | 46 | 0.260 |
Why?
| | Clostridium Infections | 2 | 2025 | 73 | 0.260 |
Why?
| | Germ-Free Life | 4 | 2025 | 34 | 0.260 |
Why?
| | Diet | 4 | 2025 | 1278 | 0.250 |
Why?
| | Evolution, Molecular | 5 | 2012 | 493 | 0.250 |
Why?
| | Genome, Bacterial | 5 | 2021 | 142 | 0.240 |
Why?
| | Mice | 15 | 2025 | 17787 | 0.240 |
Why?
| | Non-alcoholic Fatty Liver Disease | 2 | 2019 | 279 | 0.230 |
Why?
| | Phytochemicals | 1 | 2025 | 13 | 0.230 |
Why?
| | Tea | 1 | 2025 | 21 | 0.230 |
Why?
| | Ciliophora | 2 | 2003 | 15 | 0.230 |
Why?
| | RNA | 3 | 2012 | 921 | 0.230 |
Why?
| | Cohort Studies | 9 | 2021 | 5742 | 0.220 |
Why?
| | Anti-Bacterial Agents | 4 | 2025 | 1809 | 0.220 |
Why?
| | Zimbabwe | 1 | 2024 | 58 | 0.220 |
Why?
| | Receptors, CCR5 | 2 | 2021 | 56 | 0.210 |
Why?
| | Neoplasms | 1 | 2019 | 2671 | 0.210 |
Why?
| | Homeostasis | 2 | 2018 | 621 | 0.210 |
Why?
| | Lung | 2 | 2013 | 4060 | 0.200 |
Why?
| | Body Mass Index | 4 | 2019 | 2389 | 0.200 |
Why?
| | HIV | 2 | 2019 | 234 | 0.200 |
Why?
| | Colonic Neoplasms | 1 | 2025 | 258 | 0.200 |
Why?
| | Bifidobacterium | 3 | 2017 | 20 | 0.200 |
Why?
| | Internet | 2 | 2011 | 655 | 0.200 |
Why?
| | Bacteroides fragilis | 1 | 2022 | 13 | 0.190 |
Why?
| | Bacteroides | 3 | 2019 | 21 | 0.190 |
Why?
| | High-Throughput Nucleotide Sequencing | 4 | 2018 | 539 | 0.190 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 449 | 0.190 |
Why?
| | Female | 26 | 2025 | 73304 | 0.190 |
Why?
| | DNA, Ribosomal | 3 | 2013 | 88 | 0.190 |
Why?
| | Intestinal Mucosa | 2 | 2021 | 623 | 0.190 |
Why?
| | Male | 23 | 2025 | 67762 | 0.180 |
Why?
| | Base Sequence | 9 | 2017 | 2181 | 0.180 |
Why?
| | Environment | 3 | 2012 | 358 | 0.180 |
Why?
| | Peptide Termination Factors | 1 | 2001 | 5 | 0.180 |
Why?
| | Biological Evolution | 4 | 2009 | 474 | 0.180 |
Why?
| | Metabolomics | 3 | 2025 | 678 | 0.180 |
Why?
| | Infant | 8 | 2021 | 9465 | 0.180 |
Why?
| | Antiretroviral Therapy, Highly Active | 3 | 2020 | 271 | 0.180 |
Why?
| | Genetic Code | 1 | 2001 | 22 | 0.180 |
Why?
| | Firmicutes | 1 | 2021 | 19 | 0.170 |
Why?
| | RNA, Bacterial | 4 | 2010 | 190 | 0.170 |
Why?
| | Sexual Behavior | 3 | 2020 | 485 | 0.170 |
Why?
| | Intestinal Diseases, Parasitic | 1 | 2020 | 12 | 0.170 |
Why?
| | T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2020 | 7 | 0.160 |
Why?
| | Dietary Fats | 1 | 2022 | 304 | 0.160 |
Why?
| | Benzopyrans | 1 | 2019 | 26 | 0.160 |
Why?
| | Weight Reduction Programs | 1 | 2021 | 117 | 0.160 |
Why?
| | Western World | 1 | 2019 | 7 | 0.160 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2021 | 1091 | 0.150 |
Why?
| | Hypersensitivity | 1 | 2022 | 257 | 0.150 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2020 | 127 | 0.150 |
Why?
| | Thiophenes | 1 | 2019 | 117 | 0.150 |
Why?
| | Liver Regeneration | 1 | 2019 | 46 | 0.150 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2844 | 0.150 |
Why?
| | Datasets as Topic | 1 | 2019 | 121 | 0.150 |
Why?
| | Sequence Analysis | 2 | 2009 | 36 | 0.150 |
Why?
| | Behavior Therapy | 1 | 2021 | 264 | 0.140 |
Why?
| | Programmed Cell Death 1 Receptor | 2 | 2019 | 249 | 0.140 |
Why?
| | Genes, rRNA | 4 | 2017 | 41 | 0.140 |
Why?
| | Transplantation, Homologous | 1 | 2019 | 416 | 0.140 |
Why?
| | Asthma | 3 | 2022 | 2295 | 0.140 |
Why?
| | Streptococcus | 1 | 2017 | 28 | 0.140 |
Why?
| | Mouth | 1 | 2017 | 87 | 0.140 |
Why?
| | Weight Gain | 2 | 2018 | 519 | 0.130 |
Why?
| | Microbial Consortia | 1 | 2017 | 18 | 0.130 |
Why?
| | Bacterial Load | 1 | 2017 | 68 | 0.130 |
Why?
| | Gene Transfer, Horizontal | 4 | 2010 | 34 | 0.130 |
Why?
| | Environmental Microbiology | 2 | 2007 | 53 | 0.130 |
Why?
| | Algorithms | 2 | 2022 | 1704 | 0.130 |
Why?
| | Cholestasis | 1 | 2019 | 235 | 0.120 |
Why?
| | Leukemia | 1 | 2018 | 240 | 0.120 |
Why?
| | Microbial Interactions | 1 | 2016 | 18 | 0.120 |
Why?
| | Disease Models, Animal | 5 | 2024 | 4295 | 0.120 |
Why?
| | Life Style | 1 | 2018 | 490 | 0.120 |
Why?
| | Single-Cell Analysis | 1 | 2019 | 313 | 0.120 |
Why?
| | Nucleic Acid Conformation | 2 | 2012 | 728 | 0.120 |
Why?
| | Geography | 4 | 2012 | 200 | 0.120 |
Why?
| | Th17 Cells | 1 | 2016 | 108 | 0.120 |
Why?
| | Microbiology | 1 | 2015 | 24 | 0.120 |
Why?
| | Adult | 14 | 2021 | 37929 | 0.120 |
Why?
| | Weight Loss | 1 | 2021 | 787 | 0.120 |
Why?
| | Pregnancy | 4 | 2017 | 6763 | 0.120 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 209 | 0.120 |
Why?
| | Graft vs Host Disease | 1 | 2017 | 252 | 0.120 |
Why?
| | Pediatric Obesity | 2 | 2019 | 601 | 0.110 |
Why?
| | Benchmarking | 1 | 2016 | 186 | 0.110 |
Why?
| | Probability | 1 | 2015 | 304 | 0.110 |
Why?
| | Molecular Targeted Therapy | 1 | 2017 | 411 | 0.110 |
Why?
| | Sequence Alignment | 2 | 2012 | 343 | 0.110 |
Why?
| | Genomics | 2 | 2011 | 795 | 0.110 |
Why?
| | Premature Birth | 1 | 2017 | 333 | 0.110 |
Why?
| | Colitis | 1 | 2016 | 266 | 0.100 |
Why?
| | Infant, Newborn | 3 | 2020 | 6079 | 0.100 |
Why?
| | Anti-HIV Agents | 2 | 2017 | 778 | 0.100 |
Why?
| | Glucose | 1 | 2018 | 1020 | 0.100 |
Why?
| | Insulin Resistance | 2 | 2018 | 1208 | 0.100 |
Why?
| | Pets | 1 | 2013 | 26 | 0.100 |
Why?
| | Tongue | 1 | 2013 | 81 | 0.100 |
Why?
| | Pregnancy Trimester, First | 1 | 2013 | 140 | 0.100 |
Why?
| | Liver Neoplasms | 1 | 2019 | 786 | 0.100 |
Why?
| | Clostridium | 1 | 2012 | 17 | 0.100 |
Why?
| | Environmental Exposure | 1 | 2017 | 579 | 0.100 |
Why?
| | Databases, Nucleic Acid | 1 | 2012 | 34 | 0.100 |
Why?
| | Autism Spectrum Disorder | 1 | 2017 | 395 | 0.100 |
Why?
| | nef Gene Products, Human Immunodeficiency Virus | 1 | 2012 | 19 | 0.090 |
Why?
| | Cultured Milk Products | 1 | 2011 | 1 | 0.090 |
Why?
| | Colon | 2 | 2020 | 282 | 0.090 |
Why?
| | Housing | 1 | 2013 | 146 | 0.090 |
Why?
| | Antibodies, Monoclonal | 1 | 2019 | 1430 | 0.090 |
Why?
| | Fishes | 1 | 2012 | 105 | 0.090 |
Why?
| | Macaca mulatta | 2 | 2012 | 166 | 0.090 |
Why?
| | Mucin-5B | 1 | 2013 | 224 | 0.090 |
Why?
| | Simian Immunodeficiency Virus | 1 | 2012 | 88 | 0.090 |
Why?
| | Methanobrevibacter | 1 | 2011 | 1 | 0.090 |
Why?
| | Genome, Archaeal | 1 | 2011 | 12 | 0.090 |
Why?
| | Simian Acquired Immunodeficiency Syndrome | 1 | 2012 | 86 | 0.090 |
Why?
| | Respiratory Mucosa | 1 | 2013 | 321 | 0.090 |
Why?
| | Cameroon | 2 | 2021 | 9 | 0.090 |
Why?
| | Adhesins, Bacterial | 1 | 2011 | 40 | 0.090 |
Why?
| | Middle Aged | 9 | 2021 | 33479 | 0.090 |
Why?
| | Phenotype | 1 | 2019 | 3196 | 0.090 |
Why?
| | Child, Preschool | 7 | 2021 | 11074 | 0.080 |
Why?
| | RNA, Ribosomal | 2 | 2010 | 168 | 0.080 |
Why?
| | Behavioral Symptoms | 1 | 2011 | 42 | 0.080 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5757 | 0.080 |
Why?
| | Adolescent | 9 | 2021 | 21513 | 0.080 |
Why?
| | DNA Barcoding, Taxonomic | 1 | 2010 | 22 | 0.080 |
Why?
| | HIV-1 | 2 | 2018 | 864 | 0.080 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2012 | 230 | 0.080 |
Why?
| | Risk Factors | 3 | 2020 | 10388 | 0.080 |
Why?
| | Residence Characteristics | 1 | 2013 | 351 | 0.080 |
Why?
| | Child | 9 | 2022 | 21935 | 0.080 |
Why?
| | Comorbidity | 3 | 2022 | 1622 | 0.080 |
Why?
| | Young Adult | 7 | 2021 | 13209 | 0.080 |
Why?
| | Crohn Disease | 1 | 2013 | 243 | 0.080 |
Why?
| | Twins | 1 | 2011 | 243 | 0.080 |
Why?
| | Liver | 1 | 2018 | 1943 | 0.080 |
Why?
| | Surveys and Questionnaires | 2 | 2018 | 5778 | 0.080 |
Why?
| | Genome | 2 | 2010 | 300 | 0.080 |
Why?
| | Fungi | 1 | 2010 | 144 | 0.070 |
Why?
| | Viral Load | 3 | 2018 | 466 | 0.070 |
Why?
| | CD4 Lymphocyte Count | 2 | 2021 | 269 | 0.070 |
Why?
| | Virus Replication | 2 | 2012 | 483 | 0.070 |
Why?
| | Family | 1 | 2013 | 671 | 0.070 |
Why?
| | Carbohydrates | 1 | 2008 | 65 | 0.070 |
Why?
| | Norway | 2 | 2018 | 43 | 0.070 |
Why?
| | Vertebrates | 1 | 2008 | 60 | 0.070 |
Why?
| | Lentivirus Infections | 1 | 2008 | 8 | 0.070 |
Why?
| | Skin | 1 | 2013 | 752 | 0.070 |
Why?
| | Enterocolitis | 1 | 2008 | 17 | 0.070 |
Why?
| | Monkey Diseases | 1 | 2008 | 20 | 0.070 |
Why?
| | Soil | 1 | 2010 | 230 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 198 | 0.070 |
Why?
| | Antineoplastic Agents | 1 | 2019 | 2129 | 0.070 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2008 | 184 | 0.070 |
Why?
| | Sequence Analysis, RNA | 1 | 2010 | 452 | 0.070 |
Why?
| | Cytokines | 3 | 2021 | 2085 | 0.070 |
Why?
| | Postoperative Complications | 1 | 2019 | 2654 | 0.070 |
Why?
| | Adaptation, Biological | 1 | 2007 | 56 | 0.070 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2007 | 188 | 0.060 |
Why?
| | Demography | 1 | 2007 | 291 | 0.060 |
Why?
| | Mammals | 1 | 2008 | 283 | 0.060 |
Why?
| | Biomarkers | 3 | 2017 | 4149 | 0.060 |
Why?
| | Models, Biological | 2 | 2013 | 1783 | 0.060 |
Why?
| | Twins, Monozygotic | 3 | 2012 | 203 | 0.060 |
Why?
| | Viruses | 1 | 2007 | 113 | 0.060 |
Why?
| | Oligoribonucleotides | 1 | 2005 | 52 | 0.060 |
Why?
| | Polymorphism, Genetic | 2 | 2010 | 660 | 0.060 |
Why?
| | Adaptation, Physiological | 4 | 2011 | 553 | 0.060 |
Why?
| | DNA Primers | 2 | 2007 | 515 | 0.060 |
Why?
| | Neurotransmitter Agents | 2 | 2017 | 81 | 0.060 |
Why?
| | Diarrhea | 1 | 2025 | 184 | 0.050 |
Why?
| | Principal Component Analysis | 2 | 2018 | 195 | 0.050 |
Why?
| | Species Specificity | 3 | 2011 | 585 | 0.050 |
Why?
| | DNA Polymerase I | 1 | 2003 | 29 | 0.050 |
Why?
| | Age Factors | 3 | 2018 | 3295 | 0.050 |
Why?
| | Leukocyte L1 Antigen Complex | 1 | 2022 | 32 | 0.050 |
Why?
| | Plant Extracts | 1 | 2025 | 202 | 0.050 |
Why?
| | Aging | 1 | 2013 | 1864 | 0.050 |
Why?
| | National Institute of Allergy and Infectious Diseases (U.S.) | 1 | 2022 | 21 | 0.050 |
Why?
| | Recombination, Genetic | 1 | 2003 | 204 | 0.050 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2022 | 139 | 0.050 |
Why?
| | Interleukin-12 | 1 | 2022 | 121 | 0.050 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2022 | 152 | 0.050 |
Why?
| | Mental Disorders | 1 | 2011 | 1077 | 0.050 |
Why?
| | Mothers | 2 | 2018 | 754 | 0.050 |
Why?
| | Immunity | 1 | 2022 | 143 | 0.050 |
Why?
| | Codon, Terminator | 1 | 2001 | 25 | 0.040 |
Why?
| | Protein Binding | 2 | 2005 | 2224 | 0.040 |
Why?
| | Immunologic Factors | 1 | 2022 | 236 | 0.040 |
Why?
| | Twins, Dizygotic | 2 | 2012 | 175 | 0.040 |
Why?
| | Blastocystis hominis | 1 | 2020 | 1 | 0.040 |
Why?
| | Entamoeba | 1 | 2020 | 2 | 0.040 |
Why?
| | Systems Biology | 1 | 2021 | 67 | 0.040 |
Why?
| | Cryptosporidium | 1 | 2020 | 13 | 0.040 |
Why?
| | Hypertension, Pulmonary | 1 | 2012 | 1910 | 0.040 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2001 | 385 | 0.040 |
Why?
| | Integrin alpha Chains | 1 | 2020 | 24 | 0.040 |
Why?
| | Methionine-tRNA Ligase | 1 | 2019 | 1 | 0.040 |
Why?
| | Candida | 1 | 2020 | 38 | 0.040 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2020 | 42 | 0.040 |
Why?
| | Giardia lamblia | 1 | 2020 | 23 | 0.040 |
Why?
| | Aged | 5 | 2019 | 23961 | 0.040 |
Why?
| | Healthy Volunteers | 1 | 2019 | 199 | 0.040 |
Why?
| | Antibiotic Prophylaxis | 1 | 2020 | 119 | 0.040 |
Why?
| | Spondylarthritis | 1 | 2019 | 50 | 0.040 |
Why?
| | Microbial Sensitivity Tests | 1 | 2019 | 361 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 1024 | 0.040 |
Why?
| | Nucleotides | 2 | 2010 | 125 | 0.040 |
Why?
| | Colony Count, Microbial | 1 | 2018 | 120 | 0.040 |
Why?
| | 2-Propanol | 1 | 2017 | 20 | 0.040 |
Why?
| | Databases, Genetic | 2 | 2011 | 237 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 786 | 0.030 |
Why?
| | Administration, Oral | 1 | 2019 | 816 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2019 | 1092 | 0.030 |
Why?
| | Toll-Like Receptors | 1 | 2018 | 185 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2018 | 247 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2001 | 2139 | 0.030 |
Why?
| | Gene Library | 1 | 2017 | 118 | 0.030 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2017 | 84 | 0.030 |
Why?
| | HIV Protease Inhibitors | 1 | 2017 | 69 | 0.030 |
Why?
| | Epigenomics | 1 | 2017 | 115 | 0.030 |
Why?
| | Electrocardiography | 1 | 2019 | 629 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 2019 | 840 | 0.030 |
Why?
| | Biopsy | 1 | 2020 | 1129 | 0.030 |
Why?
| | Prospective Studies | 2 | 2018 | 7604 | 0.030 |
Why?
| | Transplant Recipients | 1 | 2017 | 184 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2019 | 2057 | 0.030 |
Why?
| | Statistics as Topic | 1 | 2016 | 307 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2018 | 513 | 0.030 |
Why?
| | Double-Blind Method | 1 | 2019 | 1993 | 0.030 |
Why?
| | Tissue Donors | 1 | 2017 | 425 | 0.030 |
Why?
| | Allergens | 1 | 2017 | 409 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2018 | 1142 | 0.030 |
Why?
| | Databases, Factual | 1 | 2019 | 1357 | 0.030 |
Why?
| | Air Pollution | 1 | 2017 | 316 | 0.030 |
Why?
| | Ear, Middle | 1 | 2013 | 85 | 0.030 |
Why?
| | Mucin 5AC | 1 | 2013 | 70 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3556 | 0.030 |
Why?
| | Prevalence | 1 | 2020 | 2734 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2018 | 1242 | 0.020 |
Why?
| | Overweight | 1 | 2017 | 558 | 0.020 |
Why?
| | Venezuela | 1 | 2012 | 8 | 0.020 |
Why?
| | Mutation | 1 | 2003 | 3958 | 0.020 |
Why?
| | Nucleotide Motifs | 1 | 2012 | 35 | 0.020 |
Why?
| | Malawi | 1 | 2012 | 53 | 0.020 |
Why?
| | Viral Regulatory and Accessory Proteins | 1 | 2012 | 28 | 0.020 |
Why?
| | Cilia | 1 | 2013 | 178 | 0.020 |
Why?
| | San Francisco | 1 | 2012 | 52 | 0.020 |
Why?
| | Lactobacillus | 1 | 2011 | 29 | 0.020 |
Why?
| | Dogs | 1 | 2013 | 413 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2017 | 622 | 0.020 |
Why?
| | Models, Statistical | 1 | 2016 | 669 | 0.020 |
Why?
| | Phagocytosis | 1 | 2013 | 380 | 0.020 |
Why?
| | Family Characteristics | 1 | 2013 | 191 | 0.020 |
Why?
| | Chronic Disease | 2 | 2008 | 1793 | 0.020 |
Why?
| | Programming Languages | 1 | 2011 | 26 | 0.020 |
Why?
| | Formates | 1 | 2011 | 13 | 0.020 |
Why?
| | Probiotics | 1 | 2011 | 54 | 0.020 |
Why?
| | United States | 2 | 2022 | 14841 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1325 | 0.020 |
Why?
| | Base Pairing | 1 | 2010 | 64 | 0.020 |
Why?
| | Information Storage and Retrieval | 1 | 2011 | 118 | 0.020 |
Why?
| | South America | 1 | 2010 | 60 | 0.020 |
Why?
| | Checklist | 1 | 2011 | 93 | 0.020 |
Why?
| | Ecological and Environmental Phenomena | 1 | 2009 | 6 | 0.020 |
Why?
| | DNA, Fungal | 1 | 2010 | 80 | 0.020 |
Why?
| | Citrus | 1 | 2009 | 8 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2010 | 239 | 0.020 |
Why?
| | DNA | 2 | 2007 | 1459 | 0.020 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2012 | 611 | 0.020 |
Why?
| | Staphylococcus aureus | 1 | 2013 | 450 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2018 | 1996 | 0.020 |
Why?
| | North America | 1 | 2010 | 313 | 0.020 |
Why?
| | RNA, Transfer | 1 | 2010 | 138 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 363 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2010 | 560 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2020 | 5472 | 0.020 |
Why?
| | Carnivora | 1 | 2008 | 6 | 0.020 |
Why?
| | Animals, Zoo | 1 | 2008 | 12 | 0.020 |
Why?
| | Mice, Transgenic | 1 | 2013 | 2167 | 0.020 |
Why?
| | Animals, Wild | 1 | 2008 | 59 | 0.020 |
Why?
| | Hand | 1 | 2009 | 156 | 0.020 |
Why?
| | Artificial Intelligence | 1 | 2011 | 279 | 0.020 |
Why?
| | Lentiviruses, Primate | 1 | 2008 | 13 | 0.020 |
Why?
| | Insulin | 1 | 2018 | 2409 | 0.020 |
Why?
| | Conjugation, Genetic | 1 | 2007 | 5 | 0.020 |
Why?
| | Antibodies, Blocking | 1 | 2007 | 33 | 0.020 |
Why?
| | Gene Products, gag | 1 | 2007 | 36 | 0.020 |
Why?
| | Primates | 1 | 2008 | 126 | 0.020 |
Why?
| | Gene Duplication | 1 | 2007 | 68 | 0.020 |
Why?
| | Proteobacteria | 1 | 2007 | 15 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2010 | 1062 | 0.020 |
Why?
| | Models, Molecular | 1 | 2012 | 1570 | 0.020 |
Why?
| | BRCA1 Protein | 1 | 2007 | 76 | 0.020 |
Why?
| | von Willebrand Factor | 1 | 2007 | 80 | 0.020 |
Why?
| | DNA Transposable Elements | 1 | 2007 | 121 | 0.020 |
Why?
| | Epitopes, T-Lymphocyte | 1 | 2007 | 181 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2011 | 2031 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2007 | 318 | 0.020 |
Why?
| | Computer Simulation | 1 | 2010 | 978 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3566 | 0.020 |
Why?
| | Macrophages | 1 | 2013 | 1547 | 0.020 |
Why?
| | Bacteriophages | 1 | 2007 | 98 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 2005 | 88 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 1040 | 0.010 |
Why?
| | Mice, Obese | 1 | 2005 | 66 | 0.010 |
Why?
| | B7-H1 Antigen | 1 | 2007 | 217 | 0.010 |
Why?
| | Ligands | 1 | 2007 | 664 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 2007 | 417 | 0.010 |
Why?
| | Lymph Nodes | 1 | 2007 | 491 | 0.010 |
Why?
| | Cyanobacteria | 1 | 2005 | 56 | 0.010 |
Why?
| | Up-Regulation | 1 | 2007 | 843 | 0.010 |
Why?
| | DNA, Protozoan | 1 | 2003 | 32 | 0.010 |
Why?
| | Interferon-gamma | 1 | 2007 | 789 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2003 | 155 | 0.010 |
Why?
| | Protein Conformation | 1 | 2007 | 934 | 0.010 |
Why?
| | Mosaicism | 1 | 2003 | 73 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2011 | 2189 | 0.010 |
Why?
| | Binding Sites | 1 | 2005 | 1303 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2010 | 3284 | 0.010 |
Why?
| | Haplotypes | 1 | 2003 | 494 | 0.010 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2007 | 900 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2013 | 7635 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2007 | 2475 | 0.010 |
Why?
| | Signal Transduction | 1 | 2007 | 5079 | 0.010 |
Why?
|
|
Lozupone's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|